MyFinsight
Home
Blog
About
Proceeds from sales and
maturities of investments
$226,902K
Proceeds from exercise of
common stock options
$2,081K
(196.86%↑ Y/Y)
Net cash used in
investing activities
$30,428K
(116.42%↑ Y/Y)
Net cash provided by
financing activities
$1,922K
(1148.05%↑ Y/Y)
Canceled cashflow
$196,474K
Canceled cashflow
$159K
Net decrease in cash
and cash...
-$14,064K
(94.20%↑ Y/Y)
Canceled cashflow
$32,350K
Stock-based compensation
expense
$14,334K
(17.90%↑ Y/Y)
Accrued expenses and
other current...
$7,738K
(-6.80%↓ Y/Y)
Accounts payable
$4,491K
(638.65%↑ Y/Y)
Prepaid expenses and
other current assets
-$3,184K
(-21126.67%↓ Y/Y)
Unrealized losses (gains)
on short-term...
-$3,004K
Accounts receivable, net
-$858K
Depreciation and
amortization
$850K
(372.22%↑ Y/Y)
Inventory
-$490K
Non-cash interest
expense (income)
-$46K
Non-cash lease expense
$25K
(92.31%↑ Y/Y)
Purchases of investments
$196,006K
Purchases of property and
equipment
$468K
(1460.00%↑ Y/Y)
Stock issuance costs
$139K
Withholding taxes paid on net
exercise of stock options
$20K
Net cash used in
operating activities
-$46,414K
(18.91%↑ Y/Y)
Canceled cashflow
$35,020K
Net loss
-$79,056K
(-4.19%↓ Y/Y)
Other assets
$2,053K
(15692.31%↑ Y/Y)
Other liabilities
-$325K
Back
Back
Cash Flow
CG Oncology, Inc. (CGON)
CG Oncology, Inc. (CGON)
source: myfinsight.com